Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

The HDAC Inhibitor TSA Ameliorates a Zebrafish Model of Duchenne Muscular Dystrophy.

Johnson NM, Farr GH 3rd, Maves L.

PLoS Curr. 2013 Sep 17;5. pii: ecurrents.md.8273cf41db10e2d15dd3ab827cb4b027. doi: 10.1371/currents.md.8273cf41db10e2d15dd3ab827cb4b027.

2.

Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.

Church JE, Trieu J, Chee A, Naim T, Gehrig SM, Lamon S, Angelini C, Russell AP, Lynch GS.

Exp Physiol. 2014 Apr;99(4):675-87. doi: 10.1113/expphysiol.2013.077255. Epub 2014 Jan 17.

3.

Fluoxetine prevents dystrophic changes in a zebrafish model of Duchenne muscular dystrophy.

Waugh TA, Horstick E, Hur J, Jackson SW, Davidson AE, Li X, Dowling JJ.

Hum Mol Genet. 2014 Sep 1;23(17):4651-62. doi: 10.1093/hmg/ddu185. Epub 2014 Apr 23.

4.

Muscle dysfunction and structural defects of dystrophin-null sapje mutant zebrafish larvae are rescued by ataluren treatment.

Li M, Andersson-Lendahl M, Sejersen T, Arner A.

FASEB J. 2014 Apr;28(4):1593-9. doi: 10.1096/fj.13-240044. Epub 2013 Dec 26.

5.

SU9516 Increases α7β1 Integrin and Ameliorates Disease Progression in the mdx Mouse Model of Duchenne Muscular Dystrophy.

Sarathy A, Wuebbles RD, Fontelonga TM, Tarchione AR, Mathews Griner LA, Heredia DJ, Nunes AM, Duan S, Brewer PD, Van Ry T, Hennig GW, Gould TW, Dulcey AE, Wang A, Xu X, Chen CZ, Hu X, Zheng W, Southall N, Ferrer M, Marugan J, Burkin DJ.

Mol Ther. 2017 Jun 7;25(6):1395-1407. doi: 10.1016/j.ymthe.2017.03.022. Epub 2017 Apr 5.

PMID:
28391962
6.

Evaluation of exon-skipping strategies for Duchenne muscular dystrophy utilizing dystrophin-deficient zebrafish.

Berger J, Berger S, Jacoby AS, Wilton SD, Currie PD.

J Cell Mol Med. 2011 Dec;15(12):2643-51. doi: 10.1111/j.1582-4934.2011.01260.x.

7.

Dystrophic muscle improvement in zebrafish via increased heme oxygenase signaling.

Kawahara G, Gasperini MJ, Myers JA, Widrick JJ, Eran A, Serafini PR, Alexander MS, Pletcher MT, Morris CA, Kunkel LM.

Hum Mol Genet. 2014 Apr 1;23(7):1869-78. doi: 10.1093/hmg/ddt579. Epub 2013 Nov 13. Erratum in: Hum Mol Genet. 2015 Aug 1;24(15):4480-1.

8.

Identification of a zebrafish model of muscular dystrophy.

Bassett D, Currie PD.

Clin Exp Pharmacol Physiol. 2004 Aug;31(8):537-40.

PMID:
15298547
9.

Quantification of birefringence readily measures the level of muscle damage in zebrafish.

Berger J, Sztal T, Currie PD.

Biochem Biophys Res Commun. 2012 Jul 13;423(4):785-8. doi: 10.1016/j.bbrc.2012.06.040. Epub 2012 Jun 16.

PMID:
22713473
10.

Extensive and prolonged restoration of dystrophin expression with vivo-morpholino-mediated multiple exon skipping in dystrophic dogs.

Yokota T, Nakamura A, Nagata T, Saito T, Kobayashi M, Aoki Y, Echigoya Y, Partridge T, Hoffman EP, Takeda S.

Nucleic Acid Ther. 2012 Oct;22(5):306-15. doi: 10.1089/nat.2012.0368. Epub 2012 Aug 13.

11.

Muscle dysfunction in a zebrafish model of Duchenne muscular dystrophy.

Widrick JJ, Alexander MS, Sanchez B, Gibbs DE, Kawahara G, Beggs AH, Kunkel LM.

Physiol Genomics. 2016 Nov 1;48(11):850-860. doi: 10.1152/physiolgenomics.00088.2016. Epub 2016 Oct 7.

12.

Drug screening in a zebrafish model of Duchenne muscular dystrophy.

Kawahara G, Karpf JA, Myers JA, Alexander MS, Guyon JR, Kunkel LM.

Proc Natl Acad Sci U S A. 2011 Mar 29;108(13):5331-6. doi: 10.1073/pnas.1102116108. Epub 2011 Mar 14.

13.
14.

P2RX7 purinoceptor: a therapeutic target for ameliorating the symptoms of duchenne muscular dystrophy.

Sinadinos A, Young CN, Al-Khalidi R, Teti A, Kalinski P, Mohamad S, Floriot L, Henry T, Tozzi G, Jiang T, Wurtz O, Lefebvre A, Shugay M, Tong J, Vaudry D, Arkle S, doRego JC, Górecki DC.

PLoS Med. 2015 Oct 13;12(10):e1001888. doi: 10.1371/journal.pmed.1001888. eCollection 2015 Oct.

15.

Molecular mechanism of sphingosine-1-phosphate action in Duchenne muscular dystrophy.

Nguyen-Tran DH, Hait NC, Sperber H, Qi J, Fischer K, Ieronimakis N, Pantoja M, Hays A, Allegood J, Reyes M, Spiegel S, Ruohola-Baker H.

Dis Model Mech. 2014 Jan;7(1):41-54. doi: 10.1242/dmm.013631. Epub 2013 Sep 25.

16.

Current Translational Research and Murine Models For Duchenne Muscular Dystrophy.

Rodrigues M, Echigoya Y, Fukada SI, Yokota T.

J Neuromuscul Dis. 2016 Mar 3;3(1):29-48.

17.

Diagnosis and cell-based therapy for Duchenne muscular dystrophy in humans, mice, and zebrafish.

Kunkel LM, Bachrach E, Bennett RR, Guyon J, Steffen L.

J Hum Genet. 2006;51(5):397-406. Epub 2006 Apr 1. Review.

18.

Dystrophin is required for the formation of stable muscle attachments in the zebrafish embryo.

Bassett DI, Bryson-Richardson RJ, Daggett DF, Gautier P, Keenan DG, Currie PD.

Development. 2003 Dec;130(23):5851-60.

19.

Muscle ERRγ mitigates Duchenne muscular dystrophy via metabolic and angiogenic reprogramming.

Matsakas A, Yadav V, Lorca S, Narkar V.

FASEB J. 2013 Oct;27(10):4004-16. doi: 10.1096/fj.13-228296. Epub 2013 Jun 18.

PMID:
23781095
20.

Sildenafil reduces respiratory muscle weakness and fibrosis in the mdx mouse model of Duchenne muscular dystrophy.

Percival JM, Whitehead NP, Adams ME, Adamo CM, Beavo JA, Froehner SC.

J Pathol. 2012 Sep;228(1):77-87. doi: 10.1002/path.4054. Epub 2012 Jul 18.

Supplemental Content

Support Center